BlackRock Inc. - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRV and the CUSIP is 21234W202. A total of 20 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$1,0000.0%7,130
+7.0%
0.00%
Q4 2018$1,000
-75.0%
6,665
+9.5%
0.00%
Q3 2018$4,000
-50.0%
6,088
+2.6%
0.00%
Q2 2018$8,0005,9310.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
HighTower Advisors, LLC 129,733$73,0000.00%
BARCLAYS PLC 54,522$31,0000.00%
ROYAL BANK OF CANADA 7$00.00%
VANGUARD GROUP INC 325,575$183,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 3,280$2,0000.00%
Capital Advisors, Ltd. LLC 22$00.00%
UBS Group AG 9,350$5,0000.00%
Advisor Group, Inc. 35$00.00%
WELLS FARGO & COMPANY/MN 316$00.00%
NORTHERN TRUST CORP 19,935$11,0000.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders